Piper Sandler Upgrades Immunitybio Inc (IBRX) to Overweight, 'ANKTIVA Growing w/ Expansion Opps'
Tweet Send to a Friend
(Updated - May 20, 2025 6:43 AM EDT)
Piper Sandler analyst Ed Tenthoff upgraded Immunitybio Inc (NASDAQ: IBRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Ed Tenthoff upgraded Immunitybio Inc (NASDAQ: IBRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
